{
Zoetis Inc.

Companies

}
001122334455554433221100
001122334455554433221100

equine healthcare market projected to grow at 4.2 percent through 2031

The Equine Healthcare Market is projected to grow at a CAGR of 4.2% from 2024 to 2031, driven by rising demand for veterinary care, advanced treatments, and preventive measures for horses. Key players include Purina Animal Nutrition, Elanco Animal Health, and Boehringer Ingelheim, focusing on products like vaccines, pharmaceuticals, and diagnostics. The market"s expansion is fueled by increased awareness of equine health, growth in the equestrian sports industry, and advancements in veterinary technologies.
openPR.com
Zoetis Inc. Merck & Co., Inc. Vetoquinol SA Boehringer Ingelheim KG Elanco Animal Health Incorporated Ceva Sante Animale SA Purina Animal Nutrition LLC Elanco Animal Health Boehringer Ingelheim Ceva Sante Animale Equine products UK LTD Purina Animal Nutrition LLC Show more
Healthcare, Market Report
08:07 19.11.2024

germany's veterinary market poised for growth with advanced care and technology

Germany's veterinary market is characterized by advanced diagnostic technologies and a high standard of care, with a projected growth rate of 5.95% from 2023 to 2033. Key players include Boehringer Ingelheim and Zoetis, while the livestock segment is expected to dominate due to its significance in the agricultural economy. The market faces challenges such as high service costs and regulatory hurdles, but increasing awareness of animal health drives demand for veterinary services.
Spherical Insights
Boehringer Ingelheim International GmbH Elanco Animal Health Incorporated IDEXX Laboratories, Inc. Zoetis Inc. Merck & Co., Inc. Phibro Animal Health Corporation Vetoquinol SA Ceva Animal Health DEU Show more
Healthcare, Market Report
17:35 18.11.2024

france veterinary healthcare market projected to grow at 3.95 percent CAGR

Investment in research and development (R&D) in veterinary healthcare in France rose by 14.2% to 5.8 billion euros. The market is projected to grow at a CAGR of 3.95% from 2023 to 2033, driven by increasing pet ownership and concerns over animal welfare, despite challenges like counterfeit medicines and rising care costs. The therapeutics segment is expected to dominate, particularly for ruminants, as the demand for effective animal health strategies intensifies following recent disease outbreaks.
Spherical Insights
Euro Elanco Merck & Co., Inc. IDEXX Laboratories, Inc. Vetoquinol SA Zoetis Inc. Boehringer Ingelheim International GmbH Ceva Animal Health, Inc. FRA Show more
Healthcare, Market Report
17:34 18.11.2024

growth trends and challenges in the global aquaculture healthcare market

The Aquaculture Healthcare market is experiencing growth driven by increased seafood demand, rising disease incidences, and a focus on aquaculture health. Key segments include drugs, vaccines, and medicated feed additives, with distribution through veterinary hospitals and online pharmacies. Challenges such as diseases from various pathogens may impact market expansion.
openPR.com
United States Dollar Merck & Co., Inc. Alltech Archer-Daniels-Midland Company Xylem Inc. Bayer HealthCare Animal Health Inc. Benchmark Holdings plc Pentair plc Zoetis Inc. AKVA group ASA Elanco Virbac SA ARE ZAF CAN NGA DEU BEL KOR TUR SAU GBR TWN ISR MEX IND JPN AUT CHN ESP QAT COL ARG MAR SGP BRA TUN RUS FRA ITA NLD NZL AUS CHL POL USA Archer Daniels Midland Company Craig Francis Zoetis Inc. Merck & Co. Inc. Virbac S.A. Show more
Healthcare, Market Report
13:54 15.11.2024

global livestock healthcare market projected to reach 79.39 billion by 2028

The global livestock healthcare market is projected to grow from $50.74 billion in 2023 to $79.39 billion by 2028, with a CAGR of 9.6%. This growth is driven by increasing livestock populations, rising demand for animal products, and the need for effective disease prevention and management strategies. Key players include Merck, Zoetis, and Bayer, with technological advancements enhancing market dynamics.
EIN News
Elanco Animal Health Incorporated Zoetis Inc. Bayer HealthCare AG Merck & Co., Inc. Boehringer Ingelheim International GmbH CHN RUS USA JPN BRA KOR DEU GBR IND IDN AUS Bayer Healthcare AG The Archer-Daniels-Midland Company Zoetis Inc. Merck & Co Inc. Boehringer Ingelheim International GmbH Show more
Healthcare, Market Report
13:00 08.11.2024

global veterinary healthcare market projected to reach 270 billion by 2028

The global veterinary healthcare market is projected to grow from $192.55 billion in 2023 to $270.68 billion by 2028, with a CAGR of 7.0%. Key growth drivers include rising pet ownership, zoonotic disease prevalence, and advancements in telemedicine and genomic medicine. North America remains the largest market, while major players include Zoetis Inc. and Merck & Co.
EIN News
United States Dollar Eli Lilly and Company Ceva Animal Health LLC Vetoquinol India Animal Health Pvt Ltd Merck & Co., Inc. MSD Animal Health UK Ltd. IDEXX Laboratories, Inc. Zoetis Inc. C.H. Boehringer Sohn AG & Co. KG National Veterinary Associates Inc. Phirbo Animal Health Evonik Industries AG Boehringer Ingelheim GmbH Patterson Companies, Inc. Pets at Home Group Plc CHN FRA RUS JPN USA BRA KOR DEU GBR IND IDN AUS Show more
Healthcare, Market Report
02:00 05.11.2024

global animal healthcare market projected to reach 78.6 billion by 2030

The Global Animal Healthcare Market, valued at USD 42.8 billion in 2023, is projected to reach USD 78.6 billion by 2030, growing at a CAGR of 9.2%. This growth is driven by rising healthcare expenses in farms, increased demand for protein-rich foods, and the adoption of vaccines and feed additives to combat animal diseases. Key players include Zoetis Inc., Merck & Co. Inc., and Bayer AG, with significant trends in OTC and generic drugs for animals.
openPR.com
United States Dollar Zoetis Inc. Virbac Group Ceva Sante Animale SA Bayer AG Merck & Co., Inc. Ceva Santé Animale Zoetis Inc Virbac Group Merck & Co. Inc. Bayer AG Show more
Healthcare, Market Report
12:25 30.10.2024

global pet healthcare market projected to reach 353 billion by 2028

The global pet healthcare market is projected to grow from $239.29 billion in 2023 to $255.96 billion in 2024, with a CAGR of 7.0%. Key drivers include an increasing pet population, advancements in veterinary care, and a focus on preventive health. By 2028, the market is expected to reach $353.66 billion, driven by trends such as pet humanization and economic prosperity.
EIN News
Elanco Animal Health Incorporated Norbrook Laboratories Ltd. PETCO Animal Supplies Inc. Phibro Animal Health Corporation Royal Canin Merck & Co., Inc. VCA Animal Hospitals Inc. IDEXX Laboratories, Inc. Perrigo Company plc Chewy, Inc. Colgate-Palmolive Company Mars Inc. Trupanion, Inc. Nestlé S.A. Zoetis Inc. Sanofi Boehringer Ingelheim International GmbH Vetoquinol S.A. Ceva Sante Animale SA General Mills, Inc. USA IND AUS FRA DEU BRA IDN JPN RUS GBR KOR CHN Sanofi SA Mars Inc. General Mills Inc. Nestle SA Merck & Co Inc. Show more
Healthcare, Market Report
03:01 29.10.2024

companion animal healthcare market experiences significant growth and evolving trends

The companion animal healthcare market is experiencing significant growth, driven by an increase in pet ownership and demand for improved care standards. Key factors include the rise of nuclear families and government initiatives promoting veterinary products, although counterfeit drugs pose a challenge. The market is segmented by product type and animal type, with major players including Elanco, Zoetis, and Merck.
openPR.com
United States Dollar Elanco Animal Health Inc. Bayer AG Merck & Co., Inc. Zoetis Inc. Virbac SA GBR EGY USA SAU ARG RUS DEU CHN MEX CAN FRA IND ZAF JPN KOR BRA ITA ARE Donald Trump Ankit Mathur Joe Biden Show more
Healthcare, Market Report
15:01 28.10.2024

healthcare etfs offer growth potential and defensive investment strategies

Investing in healthcare ETFs offers Canadian investors a way to diversify their portfolios, which are often underweight in this sector. Despite its volatility, the healthcare sector is expected to see growth driven by an aging population, technological advancements, and increased healthcare spending. Funds like the Hamilton Healthcare Yield Maximizer ETF and Harvest Healthcare Leaders Income ETF utilize covered call strategies to enhance yields, appealing to those seeking defensive investments with growth potential.
Finance et Investissement
Eli Lilly and Company Intuitive Surgical, Inc. UnitedHealth Group Incorporated Novo Nordisk A/S Amgen Inc. Thermo Fisher Scientific Inc. Zoetis Inc. Pfizer Inc. Merck & Co., Inc. Agilent Technologies, Inc. Stryker Corporation Johnson & Johnson CAN USA Chris Cullen Novo Nordisk A/S Mike Clare Paul MacDonald Nick Piquard Show more
Finance & Economy, Market Report
09:00 03.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.